Global Opioids Drug Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
According to APO Research, The global Opioids Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report presents an overview of global market for Opioids Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioids Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioids Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioids Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Opioids Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Opioids Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
Opioids Drug segment by Company
1. To analyze and research the global Opioids Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioids Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioids Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Opioids Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioids Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioids Drug industry.
Chapter 3: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioids Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Opioids Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report presents an overview of global market for Opioids Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioids Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioids Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioids Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Opioids Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Opioids Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
Opioids Drug segment by Company
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Opioids Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioids Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioids Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Opioids Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioids Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioids Drug industry.
Chapter 3: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioids Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Opioids Drug Sales Value (2019-2030)
1.2.2 Global Opioids Drug Sales Volume (2019-2030)
1.2.3 Global Opioids Drug Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 OPIOIDS DRUG MARKET DYNAMICS
2.1 Opioids Drug Industry Trends
2.2 Opioids Drug Industry Drivers
2.3 Opioids Drug Industry Opportunities and Challenges
2.4 Opioids Drug Industry Restraints
3 OPIOIDS DRUG MARKET BY COMPANY
3.1 Global Opioids Drug Company Revenue Ranking in 2023
3.2 Global Opioids Drug Revenue by Company (2019-2024)
3.3 Global Opioids Drug Sales Volume by Company (2019-2024)
3.4 Global Opioids Drug Average Price by Company (2019-2024)
3.5 Global Opioids Drug Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Opioids Drug Company Manufacturing Base & Headquarters
3.7 Global Opioids Drug Company, Product Type & Application
3.8 Global Opioids Drug Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Opioids Drug Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Opioids Drug Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 OPIOIDS DRUG MARKET BY TYPE
4.1 Opioids Drug Type Introduction
4.1.1 Oxycodone
4.1.2 Hydromorphone
4.1.3 Codeine
4.1.4 Fentanyl
4.2 Global Opioids Drug Sales Volume by Type
4.2.1 Global Opioids Drug Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Opioids Drug Sales Volume by Type (2019-2030)
4.2.3 Global Opioids Drug Sales Volume Share by Type (2019-2030)
4.3 Global Opioids Drug Sales Value by Type
4.3.1 Global Opioids Drug Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Opioids Drug Sales Value by Type (2019-2030)
4.3.3 Global Opioids Drug Sales Value Share by Type (2019-2030)
5 OPIOIDS DRUG MARKET BY APPLICATION
5.1 Opioids Drug Application Introduction
5.1.1 Pain Relief
5.1.2 Anesthesia
5.1.3 Others
5.2 Global Opioids Drug Sales Volume by Application
5.2.1 Global Opioids Drug Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Opioids Drug Sales Volume by Application (2019-2030)
5.2.3 Global Opioids Drug Sales Volume Share by Application (2019-2030)
5.3 Global Opioids Drug Sales Value by Application
5.3.1 Global Opioids Drug Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Opioids Drug Sales Value by Application (2019-2030)
5.3.3 Global Opioids Drug Sales Value Share by Application (2019-2030)
6 OPIOIDS DRUG MARKET BY REGION
6.1 Global Opioids Drug Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Opioids Drug Sales by Region (2019-2030)
6.2.1 Global Opioids Drug Sales by Region: 2019-2024
6.2.2 Global Opioids Drug Sales by Region (2025-2030)
6.3 Global Opioids Drug Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Opioids Drug Sales Value by Region (2019-2030)
6.4.1 Global Opioids Drug Sales Value by Region: 2019-2024
6.4.2 Global Opioids Drug Sales Value by Region (2025-2030)
6.5 Global Opioids Drug Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Opioids Drug Sales Value (2019-2030)
6.6.2 North America Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Opioids Drug Sales Value (2019-2030)
6.7.2 Europe Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Opioids Drug Sales Value (2019-2030)
6.8.2 Asia-Pacific Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Opioids Drug Sales Value (2019-2030)
6.9.2 Latin America Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Opioids Drug Sales Value (2019-2030)
6.10.2 Middle East & Africa Opioids Drug Sales Value Share by Country, 2023 VS 2030
7 OPIOIDS DRUG MARKET BY COUNTRY
7.1 Global Opioids Drug Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Opioids Drug Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Opioids Drug Sales by Country (2019-2030)
7.3.1 Global Opioids Drug Sales by Country (2019-2024)
7.3.2 Global Opioids Drug Sales by Country (2025-2030)
7.4 Global Opioids Drug Sales Value by Country (2019-2030)
7.4.1 Global Opioids Drug Sales Value by Country (2019-2024)
7.4.2 Global Opioids Drug Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.5.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.6.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.7.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.8.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.9.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.10.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.11.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.12.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.13.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.14.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.15.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.16.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.17.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.18.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.19.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.20.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.21.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.22.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.23.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.1.4 Teva Opioids Drug Product Portfolio
8.1.5 Teva Recent Developments
8.2 Purdue Pharma
8.2.1 Purdue Pharma Comapny Information
8.2.2 Purdue Pharma Business Overview
8.2.3 Purdue Pharma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.2.4 Purdue Pharma Opioids Drug Product Portfolio
8.2.5 Purdue Pharma Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Opioids Drug Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Amneal Pharma
8.4.1 Amneal Pharma Comapny Information
8.4.2 Amneal Pharma Business Overview
8.4.3 Amneal Pharma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.4.4 Amneal Pharma Opioids Drug Product Portfolio
8.4.5 Amneal Pharma Recent Developments
8.5 Collegium
8.5.1 Collegium Comapny Information
8.5.2 Collegium Business Overview
8.5.3 Collegium Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.5.4 Collegium Opioids Drug Product Portfolio
8.5.5 Collegium Recent Developments
8.6 J&J
8.6.1 J&J Comapny Information
8.6.2 J&J Business Overview
8.6.3 J&J Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.6.4 J&J Opioids Drug Product Portfolio
8.6.5 J&J Recent Developments
8.7 Endo
8.7.1 Endo Comapny Information
8.7.2 Endo Business Overview
8.7.3 Endo Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.7.4 Endo Opioids Drug Product Portfolio
8.7.5 Endo Recent Developments
8.8 Pfizer
8.8.1 Pfizer Comapny Information
8.8.2 Pfizer Business Overview
8.8.3 Pfizer Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.8.4 Pfizer Opioids Drug Product Portfolio
8.8.5 Pfizer Recent Developments
8.9 INSYS
8.9.1 INSYS Comapny Information
8.9.2 INSYS Business Overview
8.9.3 INSYS Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.9.4 INSYS Opioids Drug Product Portfolio
8.9.5 INSYS Recent Developments
8.10 Mylan
8.10.1 Mylan Comapny Information
8.10.2 Mylan Business Overview
8.10.3 Mylan Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.10.4 Mylan Opioids Drug Product Portfolio
8.10.5 Mylan Recent Developments
8.11 Hikma
8.11.1 Hikma Comapny Information
8.11.2 Hikma Business Overview
8.11.3 Hikma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.11.4 Hikma Opioids Drug Product Portfolio
8.11.5 Hikma Recent Developments
8.12 Egalet
8.12.1 Egalet Comapny Information
8.12.2 Egalet Business Overview
8.12.3 Egalet Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.12.4 Egalet Opioids Drug Product Portfolio
8.12.5 Egalet Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Opioids Drug Value Chain Analysis
9.1.1 Opioids Drug Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Opioids Drug Sales Mode & Process
9.2 Opioids Drug Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Opioids Drug Distributors
9.2.3 Opioids Drug Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Opioids Drug Sales Value (2019-2030)
1.2.2 Global Opioids Drug Sales Volume (2019-2030)
1.2.3 Global Opioids Drug Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 OPIOIDS DRUG MARKET DYNAMICS
2.1 Opioids Drug Industry Trends
2.2 Opioids Drug Industry Drivers
2.3 Opioids Drug Industry Opportunities and Challenges
2.4 Opioids Drug Industry Restraints
3 OPIOIDS DRUG MARKET BY COMPANY
3.1 Global Opioids Drug Company Revenue Ranking in 2023
3.2 Global Opioids Drug Revenue by Company (2019-2024)
3.3 Global Opioids Drug Sales Volume by Company (2019-2024)
3.4 Global Opioids Drug Average Price by Company (2019-2024)
3.5 Global Opioids Drug Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Opioids Drug Company Manufacturing Base & Headquarters
3.7 Global Opioids Drug Company, Product Type & Application
3.8 Global Opioids Drug Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Opioids Drug Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Opioids Drug Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 OPIOIDS DRUG MARKET BY TYPE
4.1 Opioids Drug Type Introduction
4.1.1 Oxycodone
4.1.2 Hydromorphone
4.1.3 Codeine
4.1.4 Fentanyl
4.2 Global Opioids Drug Sales Volume by Type
4.2.1 Global Opioids Drug Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Opioids Drug Sales Volume by Type (2019-2030)
4.2.3 Global Opioids Drug Sales Volume Share by Type (2019-2030)
4.3 Global Opioids Drug Sales Value by Type
4.3.1 Global Opioids Drug Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Opioids Drug Sales Value by Type (2019-2030)
4.3.3 Global Opioids Drug Sales Value Share by Type (2019-2030)
5 OPIOIDS DRUG MARKET BY APPLICATION
5.1 Opioids Drug Application Introduction
5.1.1 Pain Relief
5.1.2 Anesthesia
5.1.3 Others
5.2 Global Opioids Drug Sales Volume by Application
5.2.1 Global Opioids Drug Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Opioids Drug Sales Volume by Application (2019-2030)
5.2.3 Global Opioids Drug Sales Volume Share by Application (2019-2030)
5.3 Global Opioids Drug Sales Value by Application
5.3.1 Global Opioids Drug Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Opioids Drug Sales Value by Application (2019-2030)
5.3.3 Global Opioids Drug Sales Value Share by Application (2019-2030)
6 OPIOIDS DRUG MARKET BY REGION
6.1 Global Opioids Drug Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Opioids Drug Sales by Region (2019-2030)
6.2.1 Global Opioids Drug Sales by Region: 2019-2024
6.2.2 Global Opioids Drug Sales by Region (2025-2030)
6.3 Global Opioids Drug Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Opioids Drug Sales Value by Region (2019-2030)
6.4.1 Global Opioids Drug Sales Value by Region: 2019-2024
6.4.2 Global Opioids Drug Sales Value by Region (2025-2030)
6.5 Global Opioids Drug Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Opioids Drug Sales Value (2019-2030)
6.6.2 North America Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Opioids Drug Sales Value (2019-2030)
6.7.2 Europe Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Opioids Drug Sales Value (2019-2030)
6.8.2 Asia-Pacific Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Opioids Drug Sales Value (2019-2030)
6.9.2 Latin America Opioids Drug Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Opioids Drug Sales Value (2019-2030)
6.10.2 Middle East & Africa Opioids Drug Sales Value Share by Country, 2023 VS 2030
7 OPIOIDS DRUG MARKET BY COUNTRY
7.1 Global Opioids Drug Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Opioids Drug Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Opioids Drug Sales by Country (2019-2030)
7.3.1 Global Opioids Drug Sales by Country (2019-2024)
7.3.2 Global Opioids Drug Sales by Country (2025-2030)
7.4 Global Opioids Drug Sales Value by Country (2019-2030)
7.4.1 Global Opioids Drug Sales Value by Country (2019-2024)
7.4.2 Global Opioids Drug Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.5.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.6.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.7.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.8.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.9.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.10.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.11.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.12.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.13.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.14.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.15.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.16.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.17.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.18.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.19.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.20.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.21.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.22.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Opioids Drug Sales Value Growth Rate (2019-2030)
7.23.2 Global Opioids Drug Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Opioids Drug Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.1.4 Teva Opioids Drug Product Portfolio
8.1.5 Teva Recent Developments
8.2 Purdue Pharma
8.2.1 Purdue Pharma Comapny Information
8.2.2 Purdue Pharma Business Overview
8.2.3 Purdue Pharma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.2.4 Purdue Pharma Opioids Drug Product Portfolio
8.2.5 Purdue Pharma Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Opioids Drug Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Amneal Pharma
8.4.1 Amneal Pharma Comapny Information
8.4.2 Amneal Pharma Business Overview
8.4.3 Amneal Pharma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.4.4 Amneal Pharma Opioids Drug Product Portfolio
8.4.5 Amneal Pharma Recent Developments
8.5 Collegium
8.5.1 Collegium Comapny Information
8.5.2 Collegium Business Overview
8.5.3 Collegium Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.5.4 Collegium Opioids Drug Product Portfolio
8.5.5 Collegium Recent Developments
8.6 J&J
8.6.1 J&J Comapny Information
8.6.2 J&J Business Overview
8.6.3 J&J Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.6.4 J&J Opioids Drug Product Portfolio
8.6.5 J&J Recent Developments
8.7 Endo
8.7.1 Endo Comapny Information
8.7.2 Endo Business Overview
8.7.3 Endo Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.7.4 Endo Opioids Drug Product Portfolio
8.7.5 Endo Recent Developments
8.8 Pfizer
8.8.1 Pfizer Comapny Information
8.8.2 Pfizer Business Overview
8.8.3 Pfizer Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.8.4 Pfizer Opioids Drug Product Portfolio
8.8.5 Pfizer Recent Developments
8.9 INSYS
8.9.1 INSYS Comapny Information
8.9.2 INSYS Business Overview
8.9.3 INSYS Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.9.4 INSYS Opioids Drug Product Portfolio
8.9.5 INSYS Recent Developments
8.10 Mylan
8.10.1 Mylan Comapny Information
8.10.2 Mylan Business Overview
8.10.3 Mylan Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.10.4 Mylan Opioids Drug Product Portfolio
8.10.5 Mylan Recent Developments
8.11 Hikma
8.11.1 Hikma Comapny Information
8.11.2 Hikma Business Overview
8.11.3 Hikma Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.11.4 Hikma Opioids Drug Product Portfolio
8.11.5 Hikma Recent Developments
8.12 Egalet
8.12.1 Egalet Comapny Information
8.12.2 Egalet Business Overview
8.12.3 Egalet Opioids Drug Sales, Value and Gross Margin (2019-2024)
8.12.4 Egalet Opioids Drug Product Portfolio
8.12.5 Egalet Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Opioids Drug Value Chain Analysis
9.1.1 Opioids Drug Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Opioids Drug Sales Mode & Process
9.2 Opioids Drug Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Opioids Drug Distributors
9.2.3 Opioids Drug Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
